Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1983 1
1984 2
1987 1
1992 2
1993 4
1994 11
1995 2
1996 13
1997 11
1998 4
1999 5
2000 11
2002 2
2003 2
2005 2
2009 1
2010 1
2014 2
2015 4
2016 2
2017 4
2019 3
2020 2
2021 6
2022 4
2023 4
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

106 results

Results by year

Filters applied: . Clear all
Page 1
Preference for the fixed-dose combination of pertuzumab and trastuzumab for subcutaneous injection in patients with HER2-positive early breast cancer (PHranceSCa): A randomised, open-label phase II study.
O'Shaughnessy J, Sousa S, Cruz J, Fallowfield L, Auvinen P, Pulido C, Cvetanovic A, Wilks S, Ribeiro L, Burotto M, Klingbiel D, Messeri D, Alexandrou A, Trask P, Fredriksson J, Machackova Z, Stamatovic L; PHranceSCa study group. O'Shaughnessy J, et al. Eur J Cancer. 2021 Jul;152:223-232. doi: 10.1016/j.ejca.2021.03.047. Epub 2021 Jun 16. Eur J Cancer. 2021. PMID: 34147014 Free article. Clinical Trial.
First-Line Nivolumab in Stage IV or Recurrent Non-Small-Cell Lung Cancer.
Carbone DP, Reck M, Paz-Ares L, Creelan B, Horn L, Steins M, Felip E, van den Heuvel MM, Ciuleanu TE, Badin F, Ready N, Hiltermann TJN, Nair S, Juergens R, Peters S, Minenza E, Wrangle JM, Rodriguez-Abreu D, Borghaei H, Blumenschein GR Jr, Villaruz LC, Havel L, Krejci J, Corral Jaime J, Chang H, Geese WJ, Bhagavatheeswaran P, Chen AC, Socinski MA; CheckMate 026 Investigators. Carbone DP, et al. N Engl J Med. 2017 Jun 22;376(25):2415-2426. doi: 10.1056/NEJMoa1613493. N Engl J Med. 2017. PMID: 28636851 Free PMC article.
Defining a Good Death: A deliberative democratic view.
Raisio H, Vartiainen P, Jekunen A. Raisio H, et al. Among authors: jekunen a. J Palliat Care. 2015;31(3):158-65. doi: 10.1177/082585971503100305. J Palliat Care. 2015. PMID: 26514021
Signaling and drug sensitivity.
Christen RD, Isonishi S, Jones JA, Jekunen AP, Hom DK, Kröning R, Gately DP, Thiebaut FB, Los G, Howell SB. Christen RD, et al. Among authors: jekunen ap. Cancer Metastasis Rev. 1994 Jun;13(2):175-89. doi: 10.1007/BF00689635. Cancer Metastasis Rev. 1994. PMID: 7923549 Review.
[Paclitaxel, a new anticancer drug].
Jekunen A, Lehtovirta P, Pyrhönen S. Jekunen A, et al. Duodecim. 1994;110(13):1235-40. Duodecim. 1994. PMID: 7497933 Review. Finnish. No abstract available.
Microdosing in early lead discovery.
Jekunen AP, Pauwels EK, Kairemo KJ. Jekunen AP, et al. Bioanalysis. 2010 Mar;2(3):421-8. doi: 10.4155/bio.09.189. Bioanalysis. 2010. PMID: 21083252 Review.
106 results